Table 2.
Copy Number Alteration count for study subjects and stratified by subject’s group according to ichorCNA.
| CNA filtering | CNA count | ||||||
|---|---|---|---|---|---|---|---|
| All subjects | 1253 (454 GAIN, 748 DEL, 51 AMP) | ||||||
| Pos-neg | 1105 (306 GAIN, 748 DEL, 51 AMP) | ||||||
| Pos-pos | 868 (382 GAIN, 435 DEL, 51 AMP) | ||||||
| Total count | GAIN | DEL | AMP | ||||
| Subject segregation | Pos-neg | Pos-pos | Pos-neg | Pos-pos | Pos-neg | Pos-pos | |
| Shared by at least 2 subjects in a group | 200 | 355 | 563 | 435 | 51 | 51 | |
| Exclusive for a particular group | 72 | 148 | 313 | 0 | 0 | 0 | |
| CNA location by chromosome | Pos-neg | Pos-pos | |||||
| CHR1 | 109 | 126 | |||||
| CHR2 | 212 | 0 | |||||
| CHR3 | 0 | 0 | |||||
| CHR4 | 97 | 97 | |||||
| CHR5 | 87 | 0 | |||||
| CHR6 | 0 | 0 | |||||
| CHR7 | 79 | 79 | |||||
| CHR8 | 88 | 88 | |||||
| CHR9 | 0 | 0 | |||||
| CHR10 | 72 | 72 | |||||
| CHR11 | 61 | 61 | |||||
| CHR12 | 0 | 17 | |||||
| CHR13 | 67 | 67 | |||||
| CHR14 | 0 | 0 | |||||
| CHR15 | 34 | 34 | |||||
| CHR16 | 64 | 64 | |||||
| CHR17 | 18 | 36 | |||||
| CHR18 | 52 | 52 | |||||
| CHR19 | 0 | 0 | |||||
| CHR20 | 35 | 35 | |||||
| CHR21 | 20 | 20 | |||||
| CHR22 | 10 | 20 | |||||
CNA Copy Number Alteration, Pos-neg Positive–negative subjects, Pos-pos Positive-positive subjects, CH chromosome, DEL Deletion, AMP Amplification, G1 Screening Subjects Group, G2 Cases Group.